GOSS - Gossamer Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
128,679
104,942
6,391
0
Selling General and Administrative
41,479
44,051
262
83
Total Operating Expenses
170,158
148,993
6,653
83
Operating Income or Loss
-170,158
-148,993
-6,653
-83
Interest Expense
-
12
118
0
Total Other Income/Expenses Net
4,047
316
-
-
Income Before Tax
-164,403
-146,969
-6,771
-83
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-164,403
-146,969
-6,771
-83
Net Income
-164,403
-146,969
-6,771
-83
Net Income available to common shareholders
-164,403
-146,969
-6,771
-83
Reported EPS
Basic
-
-2.43
-0.74
-0.00
Diluted
-
-2.43
-0.74
-0.00
Weighted average shares outstanding
Basic
-
60,402
9,161
24,831
Diluted
-
60,402
9,161
24,831
EBITDA
-
-146,660
-6,653
-83